Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts
Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis...
Saved in:
Published in | Journal of internal medicine Vol. 283; no. 1; pp. 56 - 72 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.01.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0954-6820 1365-2796 1365-2796 |
DOI | 10.1111/joim.12688 |
Cover
Abstract | Background
Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.
Objective
To investigate the association between subclinical thyroid dysfunction and bone loss.
Methods
Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach.
Results
Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person‐years of follow‐up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = −0.18 (95% CI: −0.34, −0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast, SHypo was not associated with bone loss at any site.
Conclusion
Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk. |
---|---|
AbstractList | Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.BACKGROUNDSubclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.To investigate the association between subclinical thyroid dysfunction and bone loss.OBJECTIVETo investigate the association between subclinical thyroid dysfunction and bone loss.Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach.METHODSIndividual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach.Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site.RESULTSAmongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site.Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.CONCLUSIONAmongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk. Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach. Results Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person‐years of follow‐up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = −0.18 (95% CI: −0.34, −0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast, SHypo was not associated with bone loss at any site. Conclusion Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk. Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%[Delta]BMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach. Results Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %[Delta]BMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %[Delta]BMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %[Delta]BMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%[Delta] BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%[Delta]BMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site. Conclusion Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk. Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. To investigate the association between subclinical thyroid dysfunction and bone loss. Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach. Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site. Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk. |
Author | Gogakos, A. Bauer, D. C. Robbins, J. Gussekloo, J. Fischer, K. Segna, D. Schneider, C. Fink, H. A. Peeters, R. P. Costa, B. R. Uitterlinden, A. G. Eastell, R. Aujesky, D. A. Cappola, A. R. Naylor, K. Rivadeneira Ramirez, F. Collet, T.‐H. Feller, M. Williams, G. R. Schwartz, A. Cauley, J. A. Bischoff‐Ferrari, H. A. Rodondi, N. Dorland, H. A. Blum, M. R. Aubert, C. E. |
AuthorAffiliation | 5 Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland 1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland 15 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States 6 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland 11 Department of Medicine, University of California Davis, Sacramento, United States 4 Department of Medicine, University of Minnesota, Minneapolis, United States 2 Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, United States 10 University of Pennsylvania School of Medicine, Philadelphia, PA, United States 9 Department of Internal Medicine & Department of Epidemiology, Erasmus Medical Center Rotterdam, The Netherlands 13 Department of Medicine, Imperial College London, London, United Kingdom 14 Department of Public Health and Prima |
AuthorAffiliation_xml | – name: 9 Department of Internal Medicine & Department of Epidemiology, Erasmus Medical Center Rotterdam, The Netherlands – name: 12 Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom – name: 1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland – name: 2 Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, United States – name: 13 Department of Medicine, Imperial College London, London, United Kingdom – name: 5 Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland – name: 6 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland – name: 11 Department of Medicine, University of California Davis, Sacramento, United States – name: 7 Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland – name: 8 Department of Geriatrics, University Hospital Zurich, Zurich, Switzerland – name: 14 Department of Public Health and Primary Care & Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands – name: 4 Department of Medicine, University of Minnesota, Minneapolis, United States – name: 3 Geriatric Research Education and Clinical Center, Minneapolis VA Health Care System, Minneapolis, MN, United States – name: 15 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States – name: 10 University of Pennsylvania School of Medicine, Philadelphia, PA, United States |
Author_xml | – sequence: 1 givenname: D. orcidid: 0000-0002-4315-6676 surname: Segna fullname: Segna, D. organization: University of Bern – sequence: 2 givenname: D. C. surname: Bauer fullname: Bauer, D. C. organization: University of California – sequence: 3 givenname: M. surname: Feller fullname: Feller, M. organization: University of Bern – sequence: 4 givenname: C. surname: Schneider fullname: Schneider, C. organization: University of Bern – sequence: 5 givenname: H. A. surname: Fink fullname: Fink, H. A. organization: University of Minnesota – sequence: 6 givenname: C. E. surname: Aubert fullname: Aubert, C. E. organization: University of Bern – sequence: 7 givenname: T.‐H. surname: Collet fullname: Collet, T.‐H. organization: University Hospital of Lausanne – sequence: 8 givenname: B. R. surname: Costa fullname: Costa, B. R. organization: University of Bern – sequence: 9 givenname: K. surname: Fischer fullname: Fischer, K. organization: University Hospital Zurich – sequence: 10 givenname: R. P. surname: Peeters fullname: Peeters, R. P. organization: Erasmus Medical Center – sequence: 11 givenname: A. R. surname: Cappola fullname: Cappola, A. R. organization: University of Pennsylvania School of Medicine – sequence: 12 givenname: M. R. surname: Blum fullname: Blum, M. R. organization: University of Bern – sequence: 13 givenname: H. A. surname: Dorland fullname: Dorland, H. A. organization: University of Bern – sequence: 14 givenname: J. surname: Robbins fullname: Robbins, J. organization: University of California Davis – sequence: 15 givenname: K. surname: Naylor fullname: Naylor, K. organization: University of Sheffield – sequence: 16 givenname: R. surname: Eastell fullname: Eastell, R. organization: University of Sheffield – sequence: 17 givenname: A. G. surname: Uitterlinden fullname: Uitterlinden, A. G. organization: Erasmus Medical Center – sequence: 18 givenname: F. surname: Rivadeneira Ramirez fullname: Rivadeneira Ramirez, F. organization: Erasmus Medical Center – sequence: 19 givenname: A. surname: Gogakos fullname: Gogakos, A. organization: Imperial College London – sequence: 20 givenname: J. surname: Gussekloo fullname: Gussekloo, J. organization: Leiden University Medical Center – sequence: 21 givenname: G. R. surname: Williams fullname: Williams, G. R. organization: Imperial College London – sequence: 22 givenname: A. surname: Schwartz fullname: Schwartz, A. organization: University of California – sequence: 23 givenname: J. A. surname: Cauley fullname: Cauley, J. A. organization: University of Pittsburgh – sequence: 24 givenname: D. A. surname: Aujesky fullname: Aujesky, D. A. organization: University of Bern – sequence: 25 givenname: H. A. surname: Bischoff‐Ferrari fullname: Bischoff‐Ferrari, H. A. organization: University Hospital Zurich – sequence: 26 givenname: N. surname: Rodondi fullname: Rodondi, N. email: nicolas.rodondi@insel.ch organization: University of Bern |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29034571$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV1rFDEYhYNU7LZ64w-QAW-KMDWZyeeNUIoflUpv9Dpkkne6WWaSNZlpmX9vdrcVLWJuAnmfczhvzgk6CjEAQq8JPiflvN9EP56Thkv5DK1Iy1ndCMWP0AorRmsuG3yMTnLeYExazPELdNwo3FImyAqNFzlH683kY6g6mO4BQpXnzg4-eGuGalovKXpXuSX3c7B7zgRX2bUJt1D5oippqtEHSAV3ELKflt37NsW8haK4g8rGdUxTfome92bI8OrhPkU_Pn38fvmlvr75fHV5cV1bSqWsBe84OIfb1oDogTigVGCipGEOpMLSMkloR1WnFGd9iw1hgnFRpp3rrWxP0YeD73buRnAWwlTC6W3yo0mLjsbrvyfBr_VtvNNMtEqxncHZg0GKP2fIkx59tjAMJkCcsyaKEcapIqqgb5-gmzinUNYrlJBUUdKQQr35M9HvKI9NFAAfAFu-LSfotfXTvpYS0A-aYL0rW-_K1vuyi-TdE8mj6z9hcoDv_QDLf0j99ebq20HzCw2xvSY |
CitedBy_id | crossref_primary_10_1055_a_1951_1233 crossref_primary_10_1080_10408398_2022_2107997 crossref_primary_10_1016_j_jocd_2023_03_001 crossref_primary_10_3389_fendo_2024_1301213 crossref_primary_10_1016_S2213_8587_18_30026_3 crossref_primary_10_1016_S2213_8587_18_30028_7 crossref_primary_10_1093_jbmr_zjad005 crossref_primary_10_3803_EnM_2021_1066 crossref_primary_10_1016_S2213_8587_21_00285_0 crossref_primary_10_1089_ct_2018_30_374_376 crossref_primary_10_1210_clinem_dgz058 crossref_primary_10_1007_s12020_019_02110_9 crossref_primary_10_1089_ct_2022_34_385_388 crossref_primary_10_1007_s40618_020_01359_6 crossref_primary_10_1089_thy_2021_0179 crossref_primary_10_1016_j_ando_2020_04_010 crossref_primary_10_1111_cen_14330 crossref_primary_10_1515_hmbci_2018_0039 crossref_primary_10_2174_1573399816666200324152517 crossref_primary_10_1080_17446651_2019_1575727 crossref_primary_10_1080_03007995_2023_2165811 crossref_primary_10_1210_clinem_dgab548 crossref_primary_10_1007_s12018_018_9246_z crossref_primary_10_3390_jcm9041034 crossref_primary_10_1007_s40618_021_01537_0 crossref_primary_10_3803_EnM_2023_1769 crossref_primary_10_1038_s41598_020_75776_1 crossref_primary_10_1016_j_bone_2022_116404 crossref_primary_10_1177_0300060520903666 crossref_primary_10_1080_17446651_2020_1738924 crossref_primary_10_3390_diagnostics10030149 crossref_primary_10_1007_s12020_025_04195_x crossref_primary_10_1002_jbmr_3426 crossref_primary_10_3389_fendo_2021_641560 crossref_primary_10_1016_j_beem_2022_101614 crossref_primary_10_1007_s11102_024_01437_5 crossref_primary_10_3389_fpsyt_2022_774251 crossref_primary_10_1007_s42000_024_00555_w crossref_primary_10_1016_j_fmc_2021_04_008 crossref_primary_10_1186_s12902_021_00715_8 crossref_primary_10_1515_cclm_2024_0848 crossref_primary_10_1007_s00198_021_06081_4 crossref_primary_10_3389_fendo_2023_1306232 crossref_primary_10_1186_s12902_024_01779_y crossref_primary_10_1097_SLA_0000000000002922 crossref_primary_10_2139_ssrn_4175923 crossref_primary_10_1007_s00198_021_05964_w crossref_primary_10_1038_s41574_023_00911_7 crossref_primary_10_2478_bhk_2024_0001 crossref_primary_10_1530_EJE_18_0991 crossref_primary_10_1007_s12020_020_02259_8 crossref_primary_10_1007_s41999_021_00544_x crossref_primary_10_3803_EnM_2022_1573 |
Cites_doi | 10.1016/S2213-8587(13)70045-7 10.1001/jama.2015.3656 10.1210/jcem.87.2.8182 10.1210/jc.2014-1051 10.1097/MED.0000000000000204 10.1210/jc.2015-3191 10.1111/j.1365-2265.2007.03016.x 10.1093/epirev/mxt012 10.1056/NEJM199503233321202 10.1038/nrendo.2015.71 10.1001/jama.291.2.228 10.1007/s00198-011-1768-x 10.1016/j.beem.2011.12.004 10.1136/bmj.c221 10.1007/s00198-015-3259-y 10.1089/105072503322238854 10.1359/jbmr.070814 10.1001/archinternmed.2012.402 10.1530/EJE-13-0546 10.1210/er.2006-0043 10.1007/BF02390832 10.1007/s00198-015-3221-z 10.1016/0197-2456(86)90046-2 10.7326/0003-4819-140-2-200401200-00015 10.1016/j.cct.2005.05.006 10.1001/jama.2015.5161 10.1002/jbmr.1774 10.1359/JBMR.050304 10.1371/journal.pone.0081124 10.1210/jc.2011-3058 10.1191/1740774505cn087oa 10.1093/eurheartj/ehu424 10.1186/1472-6823-11-15 10.1111/jgs.12267 10.1089/thy.2006.16.375 10.1016/0140-6736(93)92555-8 10.1210/jc.2009-2630 10.1002/jbmr.2416 10.1001/jama.2010.1361 |
ContentType | Journal Article |
Copyright | 2017 The Association for the Publication of the Journal of Internal Medicine 2017 The Association for the Publication of the Journal of Internal Medicine. Copyright © 2018 The Association for the Publication of the Journal of Internal Medicine |
Copyright_xml | – notice: 2017 The Association for the Publication of the Journal of Internal Medicine – notice: 2017 The Association for the Publication of the Journal of Internal Medicine. – notice: Copyright © 2018 The Association for the Publication of the Journal of Internal Medicine |
CorporateAuthor | the Thyroid Studies Collaboration Thyroid Studies Collaboration |
CorporateAuthor_xml | – name: the Thyroid Studies Collaboration – name: Thyroid Studies Collaboration |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL C1K K9. 7X8 5PM |
DOI | 10.1111/joim.12688 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2796 |
EndPage | 72 |
ExternalDocumentID | PMC5739958 29034571 10_1111_joim_12688 JOIM12688 |
Genre | article Meta-Analysis Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Sanofi‐Aventis – fundername: Erasmus University, Rotterdam – fundername: National Institute of Neurological Disorders and Stroke (NINDS) – fundername: Dutch Ministry for Health, Welfare and Sports – fundername: Municipality of Rotterdam – fundername: Erasmus MC – fundername: European Commission (DG XII) – fundername: National Institute of Nursing Research funderid: R01‐NR012459 – fundername: Netherlands Organisation for the Health Research and Development (ZonMw) – fundername: Eli Lilly – fundername: NHLBI NIH HHS grantid: N01 HC085082 – fundername: NIA NIH HHS grantid: U01 AG042143 – fundername: NHLBI NIH HHS grantid: U01 HL080295 – fundername: NHLBI NIH HHS grantid: N01 HC055222 – fundername: NIA NIH HHS grantid: N01 AG062103 – fundername: Medical Research Council grantid: MR/P020941/1 – fundername: NINR NIH HHS grantid: R01 NR012459 – fundername: NIA NIH HHS grantid: R01 AG028050 – fundername: NIA NIH HHS grantid: U01 AG042124 – fundername: NIAMS NIH HHS grantid: K24 AR051895 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ TEORI TR2 UB1 V8K V9Y VH1 VVN W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZCG ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QL C1K K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4488-76b6edd033ae7fe1de4470198a5de8908c5814b49b9965f30a1575675debdfc83 |
IEDL.DBID | DR2 |
ISSN | 0954-6820 1365-2796 |
IngestDate | Thu Aug 21 18:45:07 EDT 2025 Fri Jul 11 07:31:32 EDT 2025 Sat Jul 26 01:20:05 EDT 2025 Mon Jul 21 06:04:05 EDT 2025 Tue Jul 01 00:45:36 EDT 2025 Thu Apr 24 23:07:04 EDT 2025 Wed Jan 22 16:40:35 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | thyroid disease hyperthyroidism hypothyroidism bone loss bone density prospective studies |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 The Association for the Publication of the Journal of Internal Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4488-76b6edd033ae7fe1de4470198a5de8908c5814b49b9965f30a1575675debdfc83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Daniel Segna, MD, Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland. daniel.segna@insel.ch Backup contact |
ORCID | 0000-0002-4315-6676 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.12688 |
PMID | 29034571 |
PQID | 1978494121 |
PQPubID | 30713 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5739958 proquest_miscellaneous_1951564919 proquest_journals_1978494121 pubmed_primary_29034571 crossref_citationtrail_10_1111_joim_12688 crossref_primary_10_1111_joim_12688 wiley_primary_10_1111_joim_12688_JOIM12688 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2018 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of internal medicine |
PublicationTitleAlternate | J Intern Med |
PublicationYear | 2018 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2013; 28 2013; 1 2010; 304 2006; 16 2015; 100 2015; 30 2004; 140 2013; 61 2015; 11 2003; 13 2011; 11 2005; 20 2013; 169 2010; 340 1995; 332 2005; 26 2013; 8 2001; 68 1993; 341 2012; 97 2012; 172 2004; 291 1986; 7 2015; 313 2008; 29 2002; 87 2015; 22 2014; 36 2008; 23 2007; 6 2014; 35 2008; 68 2016 2005; 2 2012; 26 2016; 27 2012; 23 2014; 99 2010; 95 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 Deure WM (e_1_2_9_35_1) 2008; 68 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_42_1 e_1_2_9_20_1 e_1_2_9_40_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 Belaya ZE (e_1_2_9_39_1) 2007; 6 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – volume: 11 start-page: 418 year: 2015 end-page: 28 article-title: Short‐term and long‐term effects of osteoporosis therapies publication-title: Nat Rev Endocrinol – volume: 27 start-page: 203 year: 2016 end-page: 10 article-title: Fracture prediction from repeat BMD measurements in clinical practice publication-title: Osteoporos Int – volume: 313 start-page: 2055 year: 2015 end-page: 65 article-title: Subclinical thyroid dysfunction and fracture risk: a meta‐analysis publication-title: JAMA – volume: 23 start-page: 1699 year: 2012 end-page: 710 article-title: The effects of adiponectin and leptin on changes in bone mineral density publication-title: Osteoporos Int – volume: 172 start-page: 799 year: 2012 end-page: 809 article-title: Subclinical hyperthyroidism and the risk of coronary heart disease and mortality publication-title: Arch Intern Med – volume: 26 start-page: 569 year: 2005 end-page: 85 article-title: Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study–a large observational study of the determinants of fracture in older men publication-title: Contemp Clin Trials – volume: 332 start-page: 767 year: 1995 end-page: 73 article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group publication-title: N Engl J Med – volume: 6 start-page: 62 year: 2007 end-page: 70 article-title: Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women publication-title: Hormones (Athens) – volume: 2 start-page: 209 year: 2005 end-page: 17 article-title: Meta‐analysis of individual patient data from randomized trials: a review of methods used in practice publication-title: Clin Trials – volume: 341 start-page: 72 year: 1993 end-page: 5 article-title: Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group publication-title: Lancet – volume: 304 start-page: 1365 year: 2010 end-page: 74 article-title: Subclinical hypothyroidism and the risk of coronary heart disease and mortality publication-title: JAMA – volume: 87 start-page: 489 year: 2002 end-page: 99 article-title: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) publication-title: J Clin Endocrinol Metab – volume: 340 start-page: c221 year: 2010 article-title: Meta‐analysis of individual participant data: rationale, conduct, and reporting publication-title: BMJ – volume: 26 start-page: 431 year: 2012 end-page: 46 article-title: Natural history, diagnosis and management of subclinical thyroid dysfunction publication-title: Best Pract Res Clin Endocrinol Metab – volume: 8 start-page: e81124 year: 2013 article-title: Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post‐injury osteoporosis in spinal cord injury patients‐ a systematic review and meta‐analysis publication-title: PLoS ONE – volume: 35 start-page: 3336 year: 2014 end-page: 45 article-title: Systematic reviews and meta‐analyses of randomized trials: principles and pitfalls publication-title: Eur Heart J – year: 2016 – volume: 99 start-page: 2657 year: 2014 end-page: 64 article-title: Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study publication-title: J Clin Endocrinol Metab – volume: 13 start-page: 585 year: 2003 end-page: 93 article-title: Hyperthyroidism, bone mineral, and fracture risk–a meta‐analysis publication-title: Thyroid – volume: 27 start-page: 115 year: 2016 end-page: 25 article-title: Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta‐analysis of prospective cohort studies publication-title: Osteoporos Int – volume: 7 start-page: 177 year: 1986 end-page: 88 article-title: Meta‐analysis in clinical trials publication-title: Control Clin Trials – volume: 291 start-page: 228 year: 2004 end-page: 38 article-title: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management publication-title: JAMA – volume: 23 start-page: 75 year: 2008 end-page: 85 article-title: Risk factors for vertebral and nonvertebral fracture over 10 years: a population‐based study in women publication-title: J Bone Miner Res – volume: 61 start-page: 868 year: 2013 end-page: 74 article-title: Thyroid status and 6‐year mortality in elderly people living in a mildly iodine‐deficient area: the aging in the Chianti Area Study publication-title: J Am Geriatr Soc – volume: 68 start-page: 175 year: 2008 end-page: 81 article-title: Effects of serum TSH and FT4 levels and the TSHR‐Asp727Glu polymorphism on bone: the Rotterdam Study publication-title: Clin Endocrinol – volume: 16 start-page: 375 year: 2006 end-page: 80 article-title: The impact of overt and subclinical hyperthyroidism on skeletal muscle publication-title: Thyroid – volume: 97 start-page: 1861 year: 2012 end-page: 70 article-title: Clinical review. Risk factors for low bone mass‐related fractures in men: a systematic review and meta‐analysis publication-title: J Clin Endocrinol Metab – volume: 28 start-page: 472 year: 2013 end-page: 9 article-title: A prospective study of thyroid function, bone loss, and fractures in older men: the MrOS study publication-title: J Bone Miner Res – volume: 169 start-page: 845 year: 2013 end-page: 52 article-title: Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway publication-title: Eur J Endocrinol – volume: 1 start-page: 59 year: 2013 end-page: 70 article-title: Glucocorticoid‐induced osteoporosis: mechanisms, management, and future perspectives publication-title: Lancet Diabetes Endocrinol – volume: 68 start-page: 259 year: 2001 end-page: 70 article-title: A meta‐analysis of the effects of cigarette smoking on bone mineral density publication-title: Calcif Tissue Int – volume: 22 start-page: 490 year: 2015 end-page: 4 article-title: Bone health after menopause publication-title: Curr Opin Endocrinol Diabetes Obes – volume: 36 start-page: 137 year: 2014 end-page: 47 article-title: Negative spinal bone mineral density changes and subclinical ovulatory disturbances–prospective data in healthy premenopausal women with regular menstrual cycles publication-title: Epidemiol Rev – volume: 29 start-page: 76 year: 2008 end-page: 131 article-title: The clinical significance of subclinical thyroid dysfunction publication-title: Endocr Rev – volume: 95 start-page: 3173 year: 2010 end-page: 81 article-title: Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women publication-title: J Clin Endocrinol Metab – volume: 11 start-page: 15 year: 2011 article-title: Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men publication-title: BMC Endocr Disord – volume: 20 start-page: 1185 year: 2005 end-page: 94 article-title: Predictive value of BMD for hip and other fractures publication-title: J Bone Miner Res – volume: 140 start-page: 128 year: 2004 end-page: 41 article-title: Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. preventive services task force publication-title: Ann Intern Med – volume: 100 start-page: 4524 year: 2015 end-page: 32 article-title: Subclinical thyroid dysfunction and frailty among older men publication-title: J Clin Endocrinol Metab – volume: 30 start-page: 898 year: 2015 end-page: 905 article-title: The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register‐based time‐resolved cohort analysis publication-title: J Bone Miner Res – volume: 313 start-page: 1657 year: 2015 end-page: 65 article-title: Preferred reporting items for systematic review and meta‐analyses of individual participant data: the PRISMA‐IPD statement publication-title: JAMA – ident: e_1_2_9_20_1 doi: 10.1016/S2213-8587(13)70045-7 – ident: e_1_2_9_12_1 doi: 10.1001/jama.2015.3656 – ident: e_1_2_9_6_1 doi: 10.1210/jcem.87.2.8182 – ident: e_1_2_9_36_1 doi: 10.1210/jc.2014-1051 – ident: e_1_2_9_14_1 – ident: e_1_2_9_28_1 doi: 10.1097/MED.0000000000000204 – ident: e_1_2_9_42_1 doi: 10.1210/jc.2015-3191 – volume: 68 start-page: 175 year: 2008 ident: e_1_2_9_35_1 article-title: Effects of serum TSH and FT4 levels and the TSHR‐Asp727Glu polymorphism on bone: the Rotterdam Study publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2007.03016.x – ident: e_1_2_9_21_1 doi: 10.1093/epirev/mxt012 – volume: 6 start-page: 62 year: 2007 ident: e_1_2_9_39_1 article-title: Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women publication-title: Hormones (Athens) – ident: e_1_2_9_2_1 doi: 10.1056/NEJM199503233321202 – ident: e_1_2_9_19_1 doi: 10.1038/nrendo.2015.71 – ident: e_1_2_9_17_1 doi: 10.1001/jama.291.2.228 – ident: e_1_2_9_33_1 doi: 10.1007/s00198-011-1768-x – ident: e_1_2_9_40_1 doi: 10.1016/j.beem.2011.12.004 – ident: e_1_2_9_24_1 doi: 10.1136/bmj.c221 – ident: e_1_2_9_23_1 doi: 10.1007/s00198-015-3259-y – ident: e_1_2_9_4_1 doi: 10.1089/105072503322238854 – ident: e_1_2_9_34_1 doi: 10.1359/jbmr.070814 – ident: e_1_2_9_16_1 doi: 10.1001/archinternmed.2012.402 – ident: e_1_2_9_31_1 doi: 10.1530/EJE-13-0546 – ident: e_1_2_9_7_1 doi: 10.1210/er.2006-0043 – ident: e_1_2_9_13_1 – ident: e_1_2_9_27_1 doi: 10.1007/BF02390832 – ident: e_1_2_9_38_1 doi: 10.1007/s00198-015-3221-z – ident: e_1_2_9_29_1 doi: 10.1016/0197-2456(86)90046-2 – ident: e_1_2_9_18_1 doi: 10.7326/0003-4819-140-2-200401200-00015 – ident: e_1_2_9_43_1 doi: 10.1016/j.cct.2005.05.006 – ident: e_1_2_9_8_1 doi: 10.1001/jama.2015.5161 – ident: e_1_2_9_11_1 doi: 10.1002/jbmr.1774 – ident: e_1_2_9_9_1 doi: 10.1359/JBMR.050304 – ident: e_1_2_9_22_1 doi: 10.1371/journal.pone.0081124 – ident: e_1_2_9_26_1 doi: 10.1210/jc.2011-3058 – ident: e_1_2_9_25_1 doi: 10.1191/1740774505cn087oa – ident: e_1_2_9_30_1 doi: 10.1093/eurheartj/ehu424 – ident: e_1_2_9_3_1 doi: 10.1186/1472-6823-11-15 – ident: e_1_2_9_32_1 doi: 10.1111/jgs.12267 – ident: e_1_2_9_41_1 doi: 10.1089/thy.2006.16.375 – ident: e_1_2_9_10_1 doi: 10.1016/0140-6736(93)92555-8 – ident: e_1_2_9_37_1 doi: 10.1210/jc.2009-2630 – ident: e_1_2_9_5_1 doi: 10.1002/jbmr.2416 – ident: e_1_2_9_15_1 doi: 10.1001/jama.2010.1361 |
SSID | ssj0013060 |
Score | 2.4888282 |
SecondaryResourceType | review_article |
Snippet | Background
Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.... Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. To... Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.... Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 56 |
SubjectTerms | Absorptiometry Adults Aged Asymptomatic Diseases Biomedical materials Bone Density Bone loss Bone mineral density Data analysis Data processing Dual energy X-ray absorptiometry Female Femur Fractures Fractures, Bone - etiology Fractures, Bone - metabolism Fractures, Bone - prevention & control Health risk assessment Hip Humans Hyperthyroidism Hyperthyroidism - diagnosis Hyperthyroidism - epidemiology Hyperthyroidism - metabolism Hypothyroidism Hypothyroidism - diagnosis Hypothyroidism - epidemiology Hypothyroidism - metabolism Male prospective studies Regression analysis Risk Factors Spine Spine (lumbar) Surgical implants Thyroid thyroid disease Thyroid diseases Thyroid gland Thyroid-stimulating hormone Thyroxine |
Title | Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12688 https://www.ncbi.nlm.nih.gov/pubmed/29034571 https://www.proquest.com/docview/1978494121 https://www.proquest.com/docview/1951564919 https://pubmed.ncbi.nlm.nih.gov/PMC5739958 |
Volume | 283 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEB5CDqWXdvvYNrvZotJeuuBg2ZJtQS9L25AGsgulgVyKsSyZmm7sJXYO2V_fkfxo0pRCezP2CEsajfSNNPMJ4C3VgeaeyhxXCt9hkionYSx0EBlLkbGMKmZyhxfXwWzJ5iu-GsD7Lhem4YfoN9yMZdj52hh4Iqt9Iy_z9YR6QWQyfakfGOL8j1-8X0cIrk0RRgjBnADXuZab1Ibx9EUPV6MjiHkcKbmPYO0SNH0M37rKN5EnPybbWk7S-994Hf-3dSfwqMWm5KoZTE9goIun8GDRnr4_g_WeLkkb4EWqreyyKwkqfVPmiqhdZdZLK5cUijTZxSTHUmWhyTq3VNdEmeD5emfeY5u6nE9i7uzd1NVzWE4_ff0wc9rrGpwUfbzICQMZaKVc3090mGmqNCodEWSUcKUj4UYpjyiTTEj0sXjmuwlFrIgOi9JSZWnkn8KwwFq8BILTkFAcPRnjwSnqJVq7mmZayFCiw6ZG8K5TW5y2XObmSo3buPdpsP9i238jeNPL3jUMHn-UGnfaj1srrmKKLjYTjHp0BK_7z2h_5lAlKXS5NTLc8O0IKkbwohks_W884fqMh1g6PBhGvYDh9j78UuTfLcc3D03OMVbr0o6Sv9Q8nt98Xtins38RPoeHiP2iZjdpDMN6s9UXiK9q-cra0U-fRyUf |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwED6xITFeYMCAwjaM4AWkVHFiJ_YjQkzdWIeENmlvURw7IoKmqEkfxq_nzklDyxDS9hYlZ8X2-ezv7LvPAG-5S5yMbBmERseBMNwGuRBpgMjY6FKU3ArKHZ6eJZMLcXIpL_vYHMqF6fghhg03sgw_X5OB04b0upXPq9mYR4lSW3DXH9ARJvoa_TlECH2SMIIIESS40vXspD6QZyi7uR5dA5nXYyXXMaxfhI4edjetNp67kGJPvo-XrRkXv_5idrx1-3bhQQ9P2YduPD2CO65-DPem_QH8E5itqZP1MV6sWZpVgiVDvS_mlWX2qqEl08vltWVdgjGrsNS8dmxWebZrZil-vr2i99ioVdono2t7F22zBxdHn84_ToL-xoagQDdPBWliEmdtGMe5S0vHrUO9I4hUubRO6VAVUnFhhDboZskyDnOOcBF9FuuMLQsVP4XtGmvxHBjORNpKdGbIibM8yp0LHS-dNqlBn82O4N1Kb1nR05nTrRo_ssGtwf7LfP-N4M0g-7Mj8fin1P5K_VlvyE3G0csWWvCIj-D18BlNkM5V8trNlyQjiXJHcz2CZ91oGX4T6TAWMsXS6cY4GgSI3nvzS1198zTfMqW0Y6zWez9M_lPz7OTL8dQ_vbiJ8CvYmZxPT7PT47PPL-E-QkHVbS7tw3a7WLoDhFutOfRG9RvPXCk9 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcoLwXChjBBaSs4sRObKmXCli1hS0IUakXFMUZR0Sw2Wo3eyi_vmPnwS5FSHCLkrHieDyeb-KZzwAvuU2sjLAMQqPjQBiOQS5EGhAyNroUJUfhaoenJ8nhqTg-k2dbsN_XwrT8EMMPN2cZfr12Bn6O5bqRz6vZmEeJUtfgukjITzpI9Dn6tYcQ-hphwhAiSMjRdeSkPo9naLvpjq5gzKupkusQ1vugyS342ve-TT35Pl41Zlz8_I3Y8X8_bxduduCUHbSz6TZs2foO7Ey77fe7MFtTJusyvNhyZfrySkZaX8wrZHixdA7Ty-U1sra8mFXUal5bNqs81zVDlz3fXLj79E190Sdzh_YumuU9OJ28-_LmMOjOawgKCvJUkCYmsYhhHOc2LS1HS1onCKlyiVbpUBVScWGENhRkyTIOc05gkSIWtAbLQsX3YbumXjwERuuQRkmhjAvhkEe5taHlpdUmNRSx4Qhe9WrLio7M3J2p8SMbghoav8yP3wheDLLnLYXHH6X2eu1nnRkvM04xttCCR3wEz4fHZIBuVyWv7XzlZKQj3NFcj-BBO1mG10Q6jIVMqXW6MY0GAUfuvfmkrr55km-ZuqJj6tZrP0v-0vPs-OPR1F89-hfhZ7Dz6e0k-3B08v4x3CAcqNo_S3uw3SxW9glhrcY89SZ1CUOnJ-w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+Subclinical+Thyroid+Dysfunction+and+Change+in+Bone+Mineral+Density+in+Prospective+Cohorts&rft.jtitle=Journal+of+internal+medicine&rft.au=Segna%2C+Daniel&rft.au=Bauer%2C+Douglas+C&rft.au=Feller%2C+Martin&rft.au=Schneider%2C+Claudio&rft.date=2018-01-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=283&rft.issue=1&rft.spage=56&rft.epage=72&rft_id=info:doi/10.1111%2Fjoim.12688&rft_id=info%3Apmid%2F29034571&rft.externalDocID=PMC5739958 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon |